Genmab Investor Relations Material
Latest events
Status Update
Genmab
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Genmab
Access all reports
Segment Data
Access more data
Revenue by
Type
Royalties
Milestone revenue
Reimbursement revenue
Collaboration revenue
License revenue
Expenses by
Financials
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.
Key slides for Genmab
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
GMAB
Country
🇩🇰 Denmark